Researchers, led by Dr Kristine Lain at the University of Kentucky, USA, compared 30 pregnant women, who developed GDM later in pregnancy, with 29 pregnant women who did not develop GDM, as controls. Levels of the hormone, adiponectin, were measured from blood samples taken during the first trimester of pregnancy, at an average of 9 weeks gestation.
Adiponectin measurements were then grouped into quartiles, and the highest quartile used as a reference. All patients underwent routine screening for GDM in the second trimester of pregnancy at 24-28 weeks. Logistic regression analysis was used to assess the odds of developing GDM based on adiponectin concentration.First trimester adiponectin levels were significantly lower in women who went on to develop GDM (4.3 ± 0.4 µg/ml) compared to the control group (6.9 ± 0.6 µg/ml). Normal pregnancy adiponectin concentration is approximately 7 ± 0.8 µg/ml. Women with adiponectin levels in the lowest quartile (
Adiponectin has insulin sensitising properties, and protects against metabolic syndrome and related conditions that can lead to type 2 diabetes. Decreased levels of adiponectin are associated with an increased risk of developing type 2 diabetes, in healthy, non-pregnant individuals. Studies on adiponectin levels in GDM patients have, until now, been limited. This study shows for the first time that adiponectin concentrations are reduced as early as nine weeks into pregnancy in patients with gestational diabetes. Such changes could contribute to patients’ lifelong risk of developing type 2 diabetes, and also lead to an earlier diagnosis of GDM. This study now needs to be repeated in a larger cohort of women, with the goal of measuring adiponectin levels in the pre-pregnancy state, ultimately to determine if the low adiponectin/high GDM risk group can be identified pre-pregnancy.
Researcher Dr Kristine Lain said:
“Gestational diabetes, if untreated, leads to increased risk of neonatal complications such as excess growth, jaundice, and respiratory problems. In addition, GDM places women at an increased risk of developing type 2 diabetes later in life. We already know that adiponectin levels are reduced in gestational diabetes patients later in pregnancy, but our results show that women with gestational diabetes have detectable metabolic differences at nine weeks of gestation, much earlier than the current clinical diagnosis. At this stage of pregnancy, most women who develop gestational diabetes have normal glucose tolerance, so lower adiponectin concentrations could act as an early indicator for gestational diabetes. Using adiponectin, we may be able to predict quite early in pregnancy who is at risk of developing gestational diabetes. Our study is based on a relatively small group of women, and the role of adiponectin as a predictor of gestational diabetes now needs to be assessed in a larger cohort of patients. Although further research is needed to determine the exact relationship between adiponectin levels and glucose tolerance during pregnancy, our results suggest adiponectin levels may be an early useful marker of gestational diabetes.”
Adiponectin is a hormone released from fat cells into the bloodstream, where it plays a role in regulating glucose levels and insulin sensitivity, and protects against the umbrella of conditions that can lead to the development of type 2 diabetes. GDM can usually be treated by dietary control, but sometimes insulin may need to be taken. Women with GDM have a 30-50% risk of developing type 2 diabetes during their lifetime, compared to a 10% risk in healthy individuals.
Rebecca Dixon | alfa
Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München
Second cause of hidden hearing loss identified
20.02.2017 | Michigan Medicine - University of Michigan
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
22.02.2017 | Power and Electrical Engineering
22.02.2017 | Life Sciences
22.02.2017 | Physics and Astronomy